DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Cascade enzymatic synthesis of L -homoserine – mathematical modelling as a tool for process optimisation and design
L-Homoserine is an important compound and a building block in chemical and pharmaceutical
industry. The one-pot cascade synthesis of L-homoserine with substrate recycling catalysed by
an aldolase and a transaminase was investigated in detail, with special interest in the
reaction’s kinetics and process development. Complex relationships between the process
variables were discovered and the kinetic and reactor model were developed. In addition, new
chemical insights were developed through this model-driven process development, and for the
first time a kinetic model was proposed to describe the YfaU-catalysed reaction. The
modelling was crucial for a better understanding of the reaction system, as well as for process
optimisation. Finding a proper strategy for process improvement by manipulating the reaction
conditions, as well as developing process design, was imperative to achieve the process
metrics necessary for scale-up. Using the optimized reaction conditions in the fed-batch
reactor with a continuous formaldehyde supply, and with subsequent addition of pyruvate and
L-alanine, 80.1 g L–1 of L-homoserine was obtained with a volume productivity of 3.2 g L–1 h–1
after 25 h. These results present a 100% increase in product concentration and approximately
18% increase in volume productivity in comparison with previously published work. This
work shows the benefit of the synergistic approach of bio(chemical) knowledge and process
model development working hand-in-hand which is crucial for stronger breakthrough of
biocatalysis to chemical industry., This project has received funding from the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No. 635595 (CarbaZymes), Ministerio de Economía y Competitividad (MINECO), the Fondo Europeo de Desarrollo Regional (FEDER) (grant RTI2018-094637-B-I00) and Programación Conjunta Internacional PCI2018-092937, through the initiative ERA CoBioTech (Tralaminol). This communication reflects only the beneficiary’s view, and the European Commission is not responsible for any use that may be made of the information it contains. The authors gratefully acknowledge Prozomix Ltd (United Kingdom) for providing the enzymes., Peer reviewed